Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome): a Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Trial

NCT05764668 is registered in ClinicalTrials.gov with DoCare Pharmaceutial Technology Co.,Ltd as lead sponsor.

NCT NCT05764668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome): a Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Trial
Lead sponsor
DoCare Pharmaceutial Technology Co.,Ltd
Phase
Phase 3
Overall status
Unknown status
Start date
November 15, 2022
Completion date
August 31, 2024
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cough